Related Experiment Video
Updated: Jul 24, 2025
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
[Regulation and influence of mitochondria on macrophages during hepatitis B virus infection]
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
Insights
Hepatitis B virus (HBV) infection impacts macrophage immunity by altering mitochondrial functions. Targeting mitochondria may offer a new therapeutic strategy for chronic hepatitis B.
Area of Science:
- Immunology
- Virology
- Cell Biology
Context:
- Hepatitis B virus (HBV) infection affects 3.5% of the global population.
- Chronic HBV is a leading cause of liver cirrhosis and cancer.
- HBV infection disrupts host immune responses.
Purpose:
- To investigate the role of mitochondria in macrophage immune regulation during HBV infection.
- To explore mitochondria as a potential therapeutic target for chronic hepatitis B.
Summary:
- HBV infection modulates mitochondrial energy metabolism, oxidative stress, and autophagy in macrophages.
- These mitochondrial changes influence macrophage activation, differentiation, and cytokine secretion.
- Mitochondria act as critical signaling hubs for macrophage-driven immunity in HBV infection.
Impact:
- Mitochondria are identified as key regulators of macrophage immune function in chronic hepatitis B.
- Findings support the potential of mitochondria-targeted therapies for chronic HBV.
- This research provides a basis for novel therapeutic strategies against liver disease.
Abstract:
Hepatitis B virus (HBV) infection is an important public health concern, as approximately 3.5% of the world's population is currently chronically infected. Chronic HBV infection is the primary cause of cirrhosis, hepatocellular carcinoma, and deaths related to liver disease globally. Studies have found that in HBV infection, viruses can directly or indirectly regulate mitochondrial energy metabolism, oxidative stress, respiratory chain metabolites, and autophagy, thereby altering macrophage activation status, differentiation types, and related cytokine secretion type and quantity regulations. Therefore, mitochondria have become an important signal source for macrophages to participate in the body's immune system during HBV infection, providing a basis for mitochondria to be considered as a potential therapeutic target for chronic hepatitis B.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
11:36Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020